Skip to main content
SpringerLink
Log in

The Emergence of Modern Cancer Immunotherapy

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. SA Rosenberg JC Yang DE White SM Steinberg (1998) ArticleTitleDurability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response Ann Surg 228 307–19 Occurrence Handle10.1097/00000658-199809000-00004 Occurrence Handle1:STN:280:DyaK1cvhtlyntA%3D%3D Occurrence Handle9742914

    Article  CAS  PubMed  Google Scholar 

  2. US Kammula DE White SA Rosenberg (1998) ArticleTitleTrends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer Cancer 83 797–805 Occurrence Handle10.1002/(SICI)1097-0142(19980815)83:4<797::AID-CNCR25>3.0.CO;2-M Occurrence Handle1:CAS:528:DyaK1cXls1ansbo%3D Occurrence Handle9708948

    Article  CAS  PubMed  Google Scholar 

  3. Spanknebel K, Cheung KY, Stoutenburg J, et al. Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin 2. Ann Surg Oncol (in press)

  4. SA Rosenberg (2001) ArticleTitleProgress in human tumour immunology and immunotherapy Nature 411 380–4 Occurrence Handle10.1038/35077246 Occurrence Handle1:CAS:528:DC%2BD3MXktVSjs70%3D Occurrence Handle11357146

    Article  CAS  PubMed  Google Scholar 

  5. SA Rosenberg JC Yang NP Restifo (2004) ArticleTitleCancer immunotherapy: moving beyond current vaccines Nat Med 10 909–15 Occurrence Handle10.1038/nm1100 Occurrence Handle1:CAS:528:DC%2BD2cXntFSktL0%3D Occurrence Handle15340416

    Article  CAS  PubMed  Google Scholar 

  6. SA Rosenberg BS Packard PM Aebersold et al. (1988) ArticleTitleUse of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma Preliminary report. N Engl J Med 319 1676–80 Occurrence Handle1:STN:280:DyaL1M%2FntVKmsw%3D%3D Occurrence Handle10.1056/NEJM198812223192527

    Article  CAS  Google Scholar 

  7. ME Dudley JR Wunderlich PF Robbins et al. (2002) ArticleTitleCancer regression and autoimmunity in patients following clonal repopulation with anti-tumor lymphocytes Science 298 850–4 Occurrence Handle10.1126/science.1076514 Occurrence Handle1:CAS:528:DC%2BD38XotFSntbY%3D Occurrence Handle12242449

    Article  CAS  PubMed  Google Scholar 

  8. ME Dudley JR Wunderlich JC Yang et al. (2005) ArticleTitleAdoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 2346–2357 Occurrence Handle10.1200/JCO.2005.00.240 Occurrence Handle1:CAS:528:DC%2BD2MXjsVyhsrs%3D Occurrence Handle15800326

    Article  CAS  PubMed  Google Scholar 

  9. GQ Phan JC Yang RM Sherry et al. (2003) ArticleTitleCancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci USA 100 8372–7 Occurrence Handle10.1073/pnas.1533209100 Occurrence Handle1:CAS:528:DC%2BD3sXlsFGnt7c%3D Occurrence Handle12826605

    Article  CAS  PubMed  Google Scholar 

  10. AB Miller B Hoogstraten M Staquet A Winkler (1981) ArticleTitleReporting results of cancer treatment Cancer 47 207–14 Occurrence Handle1:STN:280:DyaL3M7htFOltw%3D%3D Occurrence Handle7459811

    CAS  PubMed  Google Scholar 

  11. P Therasse SG Arbuck EA Eisenhauer et al. (2000) ArticleTitleNew guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205–16 Occurrence Handle10.1093/jnci/92.3.205 Occurrence Handle1:STN:280:DC%2BD3c7it1Gitg%3D%3D Occurrence Handle10655437

    Article  CAS  PubMed  Google Scholar 

  12. SA Rosenberg MT Lotze LM Muul et al. (1985) ArticleTitleObservations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer N Engl J Med 313 1485–92 Occurrence Handle1:STN:280:DyaL28%2FktVehug%3D%3D Occurrence Handle3903508 Occurrence Handle10.1056/NEJM198512053132327

    Article  CAS  PubMed  Google Scholar 

  13. MT Lotze AE Chang CA Seipp C Simpson JT Vetto SA Rosenberg (1986) ArticleTitleHigh dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: responses, treatment related morbidity and histologic findings JAMA 256 3117–24 Occurrence Handle10.1001/jama.256.22.3117 Occurrence Handle1:STN:280:DyaL2s%2FmtFaqsA%3D%3D Occurrence Handle3491225

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery Branch, National Cancer Institute, National Institutes of Health, CRC, Room 3W/3-3940, 10 Center Drive, Bethesda, Maryland, 20892-1201

    Steven A. Rosenberg MD, PhD

Authors
  1. Steven A. Rosenberg MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven A. Rosenberg MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenberg, S.A. The Emergence of Modern Cancer Immunotherapy. Ann Surg Oncol 12, 344–346 (2005). https://doi.org/10.1245/ASO.2005.01.904

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2005.01.904

Keywords

Search

Navigation